The Stanford Biodesign Innovation Program will host an evening with John Abele, founder and chairman of Boston Scientific, on Feb. 2.

Abele will discuss his journey from a physics and philosophy major in college to the head of the world’s largest medical device company dedicated to developing less-invasive therapies. His company’s products treat a range of conditions that have the common goal of reducing risk, cost and recovery time for patients, particularly in cardiac cases.

The Biodesign Innovation Program focuses on the early development of new biomedical technologies. Through hands-on experience and interaction with industry leaders, the program helps participants identify clinical needs, market potential products and take the first steps in the invention, patenting and development of new biomedical technologies.

Abele will speak at 5:30 in the California Vintage Room of the Stanford Barn at 700 Welch Rd, followed by a reception. The registration fee is $45; $35 for Stanford alumni and free for Stanford faculty, staff and students with proof of status. Register at http://acteva.com/booking.cfm?bevaid=60619.

For more information, contact Teresa Robinson at 736-1159 or innovation@med.stanford.edu.